| NCT03346668 |
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia |
https://ClinicalTrials.gov/show/NCT03346668 |
Recruiting |
University of Minnesota |
2020-08-01 |
| NCT04459650 |
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer |
https://ClinicalTrials.gov/show/NCT04459650 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT03732807 |
PF-06651600 for the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03732807 |
Recruiting |
Pfizer |
2020-09-18 |
| NCT03359356 |
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) |
https://ClinicalTrials.gov/show/NCT03359356 |
Active, not recruiting |
Icahn School of Medicine at Mount Sinai |
2020-12-31 |
| NCT03331003 |
“iRestore” Light Therapy Apparatus |
https://ClinicalTrials.gov/show/NCT03331003 |
Completed |
National Taiwan University Hospital |
2016-12-15 |
| NCT03240627 |
Efficacy and Safety of LH-8 in Paediatric Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03240627 |
Recruiting |
Legacy Healthcare SA |
2020-02-01 |
| NCT03206567 |
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair |
https://ClinicalTrials.gov/show/NCT03206567 |
Completed |
Ablon Skin Institute Research Center |
2017-12-10 |
| NCT03078686 |
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03078686 |
Recruiting |
Regeneris Medical |
2025-01-22 |
| NCT03052413 |
Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females |
https://ClinicalTrials.gov/show/NCT03052413 |
Completed |
Sadick Research Group |
2017-11-10 |
| NCT03004469 |
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT03004469 |
Completed |
Polichem S.A. |
2018-03-05 |
| NCT02974868 |
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT02974868 |
Completed |
Pfizer |
2019-05-15 |
| NCT02919735 |
Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) |
https://ClinicalTrials.gov/show/NCT02919735 |
Completed |
Legacy Healthcare SA |
2018-07-31 |
| NCT02865421 |
Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02865421 |
Completed |
King Edward Medical University |
2017-08-12 |
| NCT02848300 |
Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02848300 |
Completed |
Allergan |
2016-10-31 |
| NCT02824380 |
Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT02824380 |
Completed |
Dong-A ST Co., Ltd. |
2016-10-31 |
| NCT02812342 |
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants |
https://ClinicalTrials.gov/show/NCT02812342 |
Completed |
Yale University |
2018-07-31 |
| NCT02791243 |
Photosensitization Study in Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02791243 |
Completed |
Polichem S.A. |
2016-06-30 |
| NCT02781311 |
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males |
https://ClinicalTrials.gov/show/NCT02781311 |
Completed |
Allergan |
2018-03-15 |
| NCT02729415 |
Point-of-Care Adipose-derived Cells for Hair Growth |
https://ClinicalTrials.gov/show/NCT02729415 |
Completed |
University of Florida |
2019-01-31 |
| NCT02684097 |
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata |
https://ClinicalTrials.gov/show/NCT02684097 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-11-28 |
| NCT02626780 |
Adipose-derived SVF for Treatment of Alopecia |
https://ClinicalTrials.gov/show/NCT02626780 |
Completed |
GID BIO, Inc. |
2017-01-22 |
| NCT02594046 |
The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT02594046 |
Completed |
Pusan National University Hospital |
2016-02-28 |
| NCT02591355 |
Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment |
https://ClinicalTrials.gov/show/NCT02591355 |
Completed |
Regen Lab SA |
2019-11-18 |
| NCT03315689 |
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) |
https://ClinicalTrials.gov/show/NCT03315689 |
Completed |
Aclaris Therapeutics, Inc. |
2019-06-20 |
| NCT03137381 |
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03137381 |
Completed |
Concert Pharmaceuticals |
2019-07-08 |
| NCT02561585 |
LEO 124249 Ointment in the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT02561585 |
Completed |
LEO Pharma |
2016-12-31 |
| NCT02557074 |
TREg Activation in the Treatment of the PELADE (Alopecia Areata) |
https://ClinicalTrials.gov/show/NCT02557074 |
Completed |
Centre Hospitalier Universitaire de Nice |
2019-02-02 |
| NCT03388840 |
Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction |
https://ClinicalTrials.gov/show/NCT03388840 |
Recruiting |
Assiut University |
2021-01-31 |
| NCT02503852 |
STYLE – A Trial of Cell Enriched Adipose For Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02503852 |
Completed |
Kerastem Technologies, LLC |
2018-03-02 |
| NCT02503137 |
A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing |
https://ClinicalTrials.gov/show/NCT02503137 |
Completed |
Samumed LLC |
2016-04-30 |
| NCT02460497 |
Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT02460497 |
Completed |
Galderma Laboratories, L.P. |
2015-11-30 |
| NCT02460289 |
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT02460289 |
Completed |
Galderma Laboratories, L.P. |
2015-11-30 |
| NCT02312882 |
Tofacitinib for the Treatment of Alopecia Areata and Its Variants |
https://ClinicalTrials.gov/show/NCT02312882 |
Completed |
Stanford University |
2015-08-31 |
| NCT02302053 |
Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair |
https://ClinicalTrials.gov/show/NCT02302053 |
Completed |
Ablon Skin Institute Research Center |
2014-02-28 |
| NCT02299297 |
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis |
https://ClinicalTrials.gov/show/NCT02299297 |
Completed |
Columbia University |
2017-12-31 |
| NCT02297360 |
Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair |
https://ClinicalTrials.gov/show/NCT02297360 |
Completed |
Ablon Skin Institute Research Center |
2014-04-30 |
| NCT02288858 |
To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair |
https://ClinicalTrials.gov/show/NCT02288858 |
Completed |
Irish Response t/a Lifes2good |
2011-11-30 |
| NCT02280603 |
Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application |
https://ClinicalTrials.gov/show/NCT02280603 |
Completed |
Dong-A ST Co., Ltd. |
2014-12-31 |
| NCT02279823 |
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02279823 |
Completed |
Intrepid Therapeutics, Inc. |
2015-12-31 |
| NCT02275351 |
A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) |
https://ClinicalTrials.gov/show/NCT02275351 |
Completed |
Samumed LLC |
2015-11-30 |
| NCT02197455 |
Tofacitnib for the Treatment of Alopecia Areata and Variants |
https://ClinicalTrials.gov/show/NCT02197455 |
Completed |
Yale University |
2015-07-31 |
| NCT02170662 |
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles |
https://ClinicalTrials.gov/show/NCT02170662 |
Completed |
Duke University |
2011-05-31 |
| NCT02150187 |
Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss |
https://ClinicalTrials.gov/show/NCT02150187 |
Completed |
Family Marketing |
2015-02-28 |
| NCT02087319 |
Effect of PRP on the Therapy for Hair Growth |
https://ClinicalTrials.gov/show/NCT02087319 |
Completed |
China Medical University Hospital |
2015-06-30 |
| NCT02067260 |
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males |
https://ClinicalTrials.gov/show/NCT02067260 |
Completed |
Spencer Forrest, Inc. |
2010-04-30 |
| NCT01309191 |
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment |
https://ClinicalTrials.gov/show/NCT01309191 |
Completed |
University Hospitals Cleveland Medical Center |
2012-04-30 |
| NCT01286649 |
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01286649 |
Completed |
RepliCel Life Sciences, Inc. |
2012-04-30 |
| NCT02037191 |
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade |
https://ClinicalTrials.gov/show/NCT02037191 |
Completed |
University Hospital, Rouen |
2017-12-31 |
| NCT02018042 |
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata |
https://ClinicalTrials.gov/show/NCT02018042 |
Completed |
Columbia University |
2017-07-31 |
| NCT02014584 |
Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT02014584 |
Completed |
GlaxoSmithKline |
2016-03-19 |
| NCT01986140 |
Scalp Cooling to Prevent Chemo-induced Hair Loss |
https://ClinicalTrials.gov/show/NCT01986140 |
Active, not recruiting |
Baylor Breast Care Center |
2017-02-10 |
| NCT01967277 |
A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy |
https://ClinicalTrials.gov/show/NCT01967277 |
Completed |
Capillus, LLC |
2014-08-31 |
| NCT01950780 |
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01950780 |
Completed |
Columbia University |
2016-04-30 |
| NCT01929330 |
Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT01929330 |
Completed |
GlaxoSmithKline |
2014-01-09 |
| NCT04450602 |
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss |
https://ClinicalTrials.gov/show/NCT04450602 |
Completed |
Arbor Life Labs |
2018-10-20 |
| NCT04450589 |
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss |
https://ClinicalTrials.gov/show/NCT04450589 |
Completed |
Arbor Life Labs |
2018-10-23 |
| NCT01904721 |
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) |
https://ClinicalTrials.gov/show/NCT01904721 |
Completed |
Allergan |
2014-09-30 |
| NCT01900041 |
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT01900041 |
Completed |
Merz Pharmaceuticals GmbH |
2013-05-31 |
| NCT03351322 |
ENERGI-F701 for Female Hair Loss Treatment |
https://ClinicalTrials.gov/show/NCT03351322 |
Recruiting |
Energenesis Biomedical Co., Ltd. |
2019-10-03 |
| NCT01852487 |
Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01852487 |
Completed |
Dream Plus |
2012-12-31 |
| NCT01831791 |
A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01831791 |
Completed |
GlaxoSmithKline |
2014-07-19 |
| NCT01831024 |
Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia |
https://ClinicalTrials.gov/show/NCT01831024 |
Active, not recruiting |
Target Health Inc. |
2020-10-31 |
| NCT01797432 |
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01797432 |
Completed |
University of Minnesota |
2014-11-30 |
| NCT01701271 |
Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females |
https://ClinicalTrials.gov/show/NCT01701271 |
Completed |
Mexis George |
2001-06-30 |
| NCT01669746 |
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) |
https://ClinicalTrials.gov/show/NCT01669746 |
Completed |
Aderans Research Institute |
2013-04-30 |
| NCT01559584 |
Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01559584 |
Completed |
Cairo University |
2014-03-31 |
| NCT01520077 |
Vytorin in the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01520077 |
Completed |
University of Miami |
2015-01-31 |
| NCT01325337 |
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT01325337 |
Completed |
Allergan |
2012-08-31 |
| NCT01453686 |
A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01453686 |
Completed |
The Hospital for Sick Children |
2003-08-31 |
| NCT01451190 |
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) |
https://ClinicalTrials.gov/show/NCT01451190 |
Completed |
Aderans Research Institute |
2013-03-31 |
| NCT01451177 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) |
https://ClinicalTrials.gov/show/NCT01451177 |
Completed |
Aderans Research Institute |
2012-01-31 |
| NCT01451151 |
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) |
https://ClinicalTrials.gov/show/NCT01451151 |
Completed |
Aderans Research Institute |
2012-06-30 |
| NCT01451138 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) |
https://ClinicalTrials.gov/show/NCT01451138 |
Completed |
Aderans Research Institute |
2012-10-31 |
| NCT01451125 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) |
https://ClinicalTrials.gov/show/NCT01451125 |
Completed |
Aderans Research Institute |
2012-03-31 |
| NCT01451112 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) |
https://ClinicalTrials.gov/show/NCT01451112 |
Completed |
Aderans Research Institute |
2012-08-31 |
| NCT01451099 |
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss |
https://ClinicalTrials.gov/show/NCT01451099 |
Completed |
Aderans Research Institute |
2010-09-30 |
| NCT01451073 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) |
https://ClinicalTrials.gov/show/NCT01451073 |
Completed |
Aderans Research Institute |
2010-08-31 |
| NCT01451047 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) |
https://ClinicalTrials.gov/show/NCT01451047 |
Completed |
Aderans Research Institute |
2011-04-30 |
| NCT01437163 |
Treatment of Androgenetic Alopecia in Males and Females |
https://ClinicalTrials.gov/show/NCT01437163 |
Completed |
Apira Science, Inc. |
2013-08-31 |
| NCT01391156 |
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT01391156 |
Completed |
Mae Fah Luang University Hospital |
2012-03-31 |
| NCT04435847 |
Safety and Efficacy of HST 001 in Male Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT04435847 |
Recruiting |
Histogen |
2021-01-31 |
| NCT04412148 |
Modified SALT Score for Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04412148 |
Recruiting |
Kasr El Aini Hospital |
2020-07-01 |
| NCT04409041 |
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia |
https://ClinicalTrials.gov/show/NCT04409041 |
Active, not recruiting |
Washington University School of Medicine |
2020-12-31 |
| NCT04346316 |
A Phase II Study in Patients With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04346316 |
Recruiting |
Reistone Biopharma Company Limited |
2021-07-31 |
| NCT04299503 |
Topical Crisaborole in Patients With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04299503 |
Recruiting |
Tufts Medical Center |
2021-03-31 |
| NCT04238091 |
Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04238091 |
Recruiting |
Columbia University |
2022-12-31 |
| NCT04228029 |
Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids |
https://ClinicalTrials.gov/show/NCT04228029 |
Active, not recruiting |
Kasr El Aini Hospital |
2020-02-20 |
| NCT04209803 |
N-Acetyl-Cysteine for Treatment of AGA in Men |
https://ClinicalTrials.gov/show/NCT04209803 |
Recruiting |
Kafrelsheikh University |
2020-09-30 |
| NCT04207931 |
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study |
https://ClinicalTrials.gov/show/NCT04207931 |
Recruiting |
Wake Forest University Health Sciences |
2021-11-30 |
| NCT04205214 |
A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia |
https://ClinicalTrials.gov/show/NCT04205214 |
Active, not recruiting |
City, University of London |
2019-12-13 |
| NCT04090801 |
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT04090801 |
Completed |
Sohag University |
2016-05-30 |
| NCT04048031 |
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair |
https://ClinicalTrials.gov/show/NCT04048031 |
Recruiting |
Ablon Skin Institute Research Center |
2021-01-31 |
| NCT04034134 |
Jaktinib Dihydrochloride Monohydrate in Severe Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04034134 |
Recruiting |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
2020-09-01 |
| NCT04019795 |
Modulated Light Therapy in Participants With Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT04019795 |
Completed |
PhotonMD, Inc |
2019-05-25 |
| NCT04006457 |
Long-Term PF-06651600 for the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04006457 |
Recruiting |
Pfizer |
2023-05-01 |
| NCT04003376 |
Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04003376 |
Recruiting |
Assiut University |
2021-07-01 |
| NCT03941548 |
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03941548 |
Active, not recruiting |
Concert Pharmaceuticals |
2020-03-31 |
| NCT03938948 |
Low Level Light Therapy (LLLT) for Hair Growth |
https://ClinicalTrials.gov/show/NCT03938948 |
Recruiting |
Awareable Technologies Inc |
2020-12-31 |
| NCT03899259 |
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03899259 |
Recruiting |
Eli Lilly and Company |
2021-02-05 |
| NCT03898479 |
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03898479 |
Active, not recruiting |
Concert Pharmaceuticals |
2022-02-28 |
| NCT03873155 |
The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03873155 |
Completed |
University of Sheffield |
2019-08-20 |
| NCT03852992 |
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT03852992 |
Recruiting |
University of Minnesota |
2021-07-01 |
| NCT03847441 |
Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03847441 |
Completed |
Aswan University Hospital |
2018-12-31 |
| NCT03831334 |
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia |
https://ClinicalTrials.gov/show/NCT03831334 |
Recruiting |
Northwestern University |
2020-12-31 |
| NCT03811912 |
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03811912 |
Completed |
Concert Pharmaceuticals |
2019-11-21 |
| NCT03753113 |
Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% |
https://ClinicalTrials.gov/show/NCT03753113 |
Completed |
Tabriz University of Medical Sciences |
2019-09-02 |
| NCT03742518 |
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT03742518 |
Active, not recruiting |
Samumed LLC |
2021-01-31 |
| NCT03712696 |
Efficacy and Safety of DIGNICAPâ„¢ System |
https://ClinicalTrials.gov/show/NCT03712696 |
Completed |
European Institute of Oncology |
2018-04-30 |
| NCT03709563 |
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss |
https://ClinicalTrials.gov/show/NCT03709563 |
Active, not recruiting |
DeNova Research |
2020-07-02 |
| NCT03689452 |
The Effect of Platelet Rich Plasma on Non-scarring Alopecia |
https://ClinicalTrials.gov/show/NCT03689452 |
Completed |
Icahn School of Medicine at Mount Sinai |
2019-06-03 |
| NCT03676400 |
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia |
https://ClinicalTrials.gov/show/NCT03676400 |
Completed |
Medipost Co Ltd. |
2019-07-22 |
| NCT03651752 |
DPCP for the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03651752 |
Recruiting |
University of Minnesota |
2020-09-01 |
| NCT03630198 |
Pain Outcomes Following Intralesional Corticosteroid Injections |
https://ClinicalTrials.gov/show/NCT03630198 |
Recruiting |
Vanderbilt University Medical Center |
2019-09-30 |
| NCT03594227 |
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis |
https://ClinicalTrials.gov/show/NCT03594227 |
Completed |
Aclaris Therapeutics, Inc. |
2019-06-06 |
| NCT03570749 |
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03570749 |
Active, not recruiting |
Eli Lilly and Company |
2021-02-11 |
| NCT03551821 |
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03551821 |
Completed |
Aclaris Therapeutics, Inc. |
2018-11-06 |
| NCT03535233 |
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03535233 |
Completed |
Cairo University |
2017-06-30 |
| NCT03521687 |
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA) |
https://ClinicalTrials.gov/show/NCT03521687 |
Recruiting |
Icahn School of Medicine at Mount Sinai |
2019-10-15 |
| NCT03495817 |
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution |
https://ClinicalTrials.gov/show/NCT03495817 |
Active, not recruiting |
Aclaris Therapeutics, Inc. |
2019-10-30 |
| NCT03491267 |
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis |
https://ClinicalTrials.gov/show/NCT03491267 |
Enrolling by invitation |
Johns Hopkins University |
2025-12-31 |
| NCT03488108 |
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women |
https://ClinicalTrials.gov/show/NCT03488108 |
Completed |
Mayo Clinic |
2018-05-31 |
| NCT03422640 |
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia |
https://ClinicalTrials.gov/show/NCT03422640 |
Recruiting |
Bellevue Dermatology |
2019-01-31 |
| NCT01246284 |
The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01246284 |
Completed |
University of British Columbia |
2014-07-31 |
| NCT01231607 |
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01231607 |
Completed |
GlaxoSmithKline |
2012-02-01 |
| NCT01226459 |
Clinical Trial in Females for Female Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT01226459 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2011-08-31 |
| NCT01189279 |
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia |
https://ClinicalTrials.gov/show/NCT01189279 |
Completed |
Allergan |
2011-01-31 |
| NCT01167946 |
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata |
https://ClinicalTrials.gov/show/NCT01167946 |
Completed |
King Saud University |
2009-12-31 |
| NCT01145625 |
Clinical Trial in Females With Female Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT01145625 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2012-02-29 |
| NCT01052870 |
Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01052870 |
Completed |
HairDx, LLC |
2009-12-31 |
| NCT01023841 |
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children |
https://ClinicalTrials.gov/show/NCT01023841 |
Completed |
Allergan |
2012-11-02 |
| NCT01016964 |
Treatment of Androgenetic Alopecia in Females, 12 Beam |
https://ClinicalTrials.gov/show/NCT01016964 |
Completed |
Lexington International, LLC |
2011-03-31 |
| NCT01008774 |
START: Swiss Taxotere Alopecia Prevention Trial |
https://ClinicalTrials.gov/show/NCT01008774 |
Completed |
Sanofi |
2011-10-31 |
| NCT00997815 |
The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis |
https://ClinicalTrials.gov/show/NCT00997815 |
Completed |
Siriraj Hospital |
2010-12-31 |
| NCT00981461 |
Treatment of Androgenetic Alopecia in Females, 9 Beam |
https://ClinicalTrials.gov/show/NCT00981461 |
Completed |
Lexington International, LLC |
2010-10-31 |
| NCT00965640 |
Treatment of Male Pattern Baldness With Botulinum Toxin |
https://ClinicalTrials.gov/show/NCT00965640 |
Completed |
The Crown Institute |
2004-06-30 |
| NCT00958750 |
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT00958750 |
Completed |
Charite University, Berlin, Germany |
2009-02-28 |
| NCT00947505 |
Treatment of Androgenetic Alopecia in Males |
https://ClinicalTrials.gov/show/NCT00947505 |
Completed |
Lexington International, LLC |
2010-08-31 |
| NCT00947219 |
Treatment of Androgenic Alopecia in Males |
https://ClinicalTrials.gov/show/NCT00947219 |
Completed |
Lexington International, LLC |
2010-08-31 |
| NCT03800979 |
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata |
https://ClinicalTrials.gov/show/NCT03800979 |
Active, not recruiting |
Institute of Dermatology, Thailand |
2020-09-30 |
| NCT01590238 |
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) |
https://ClinicalTrials.gov/show/NCT01590238 |
Completed |
The New York Eye & Ear Infirmary |
2013-09-30 |
| NCT01451021 |
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss |
https://ClinicalTrials.gov/show/NCT01451021 |
Completed |
Aderans Research Institute |
2010-06-30 |
| NCT01319370 |
Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT01319370 |
Completed |
Charite University, Berlin, Germany |
2013-03-31 |
| NCT02350023 |
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata |
https://ClinicalTrials.gov/show/NCT02350023 |
Completed |
Postgraduate Institute of Medical Education and Research |
2015-03-31 |
| NCT04147845 |
Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata |
https://ClinicalTrials.gov/show/NCT04147845 |
Recruiting |
Alexandria University |
2020-10-31 |
| NCT00515762 |
Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling |
https://ClinicalTrials.gov/show/NCT00515762 |
Completed |
Hospital San Carlos, Madrid |
2010-06-30 |
| NCT00484679 |
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00484679 |
Completed |
University of Minnesota |
2009-06-30 |
| NCT00441116 |
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia |
https://ClinicalTrials.gov/show/NCT00441116 |
Completed |
GlaxoSmithKline |
2008-01-21 |
| NCT00418730 |
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT00418730 |
Completed |
Neosil, Inc. |
2007-10-31 |
| NCT00408798 |
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin |
https://ClinicalTrials.gov/show/NCT00408798 |
Completed |
University of British Columbia |
2009-10-30 |
| NCT00396175 |
Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) |
https://ClinicalTrials.gov/show/NCT00396175 |
Completed |
Merck Sharp & Dohme Corp. |
2000-01-31 |
| NCT00187577 |
Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00187577 |
Completed |
University of California, San Francisco |
2006-02-28 |
| NCT00177021 |
Aldara for the Treatment of Extensive Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00177021 |
Completed |
University of Minnesota |
NA |
| NCT00176982 |
Plaquenil for Alopecia Areata, Alopecia Totalis |
https://ClinicalTrials.gov/show/NCT00176982 |
Completed |
University of Minnesota |
2007-12-31 |
| NCT00176969 |
Response of Topical Capsaicin in Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00176969 |
Completed |
University of Minnesota |
NA |
| NCT00176943 |
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% |
https://ClinicalTrials.gov/show/NCT00176943 |
Completed |
University of Minnesota |
2002-08-31 |
| NCT00175617 |
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT00175617 |
Completed |
University of British Columbia |
2009-03-09 |
| NCT00167102 |
Alefacept in Patients With Severe Scalp Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00167102 |
Completed |
University of Minnesota |
2008-02-29 |
| NCT00151515 |
A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss |
https://ClinicalTrials.gov/show/NCT00151515 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2004-07-31 |
| NCT00063076 |
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata |
https://ClinicalTrials.gov/show/NCT00063076 |
Completed |
M.D. Anderson Cancer Center |
2006-10-31 |